Nicholas Company, Inc. Abbott Laboratories Transaction History

Nicholas Company, Inc.

$5.92 Billion
Q1 2024

A detailed history of Nicholas Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Nicholas Company, Inc. holds 89,350 shares of ABT stock, worth $9.29 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

89,350

Previous 89,350 -0.0%

Holding current value

$9.29 Million

Previous $9.83 Million 3.26%

% of portfolio

0.17%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $411,266 - $503,424	4,560 Added 5.38%	89,350 $9.83 Million
Q3 2023 Feb 13, 2024	SELL	$95.53 - $114.62 $35,346 - $42,409	-370 Reduced 0.43%	84,790 $8.21 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $35,346 - $42,409	-370 Reduced 0.43%	84,790 $8.21 Million
Q2 2023 Feb 13, 2024	BUY	$100.78 - $112.29 $4,031 - $4,491	40 Added 0.05%	85,160 $9.28 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $4,031 - $4,491	40 Added 0.05%	85,160 $9.28 Million

Q4 2022 Feb 13, 2024	BUY	$95.06 - $111.52 $1.34 Million - $1.57 Million	14,105 Added 19.86%	85,120 $9.35 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $1.34 Million - $1.57 Million	14,105 Added 19.86%	85,120 $9.35 Million
Q2 2022 Feb 13, 2024	BUY	$102.07 - $123.37 $875,760 - $1.06 Million	8,580 Added 13.74%	71,015 $7.72 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $875,760 - $1.06 Million	8,580 Added 13.74%	71,015 $7.72 Million
Q1 2022 Feb 13, 2024	SELL	$114.02 - $139.04 $2.55 Million - $3.11 Million	-22,355 Reduced 26.37%	62,435 $7.39 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $68,412 - $83,424	-600 Reduced 0.95%	62,435 $7.39 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $69,996 - $77,436	-600 Reduced 0.94%	63,035 $7.45 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $532,652 - $627,008	5,035 Added 8.59%	63,635 $7.38 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $1.38 Million - $1.63 Million	-12,675 Reduced 17.78%	58,600 $7.02 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $494,025 - $538,346	-4,705 Reduced 6.19%	71,275 $7.8 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $973,216 - $1.18 Million	-10,620 Reduced 12.26%	75,980 $8.27 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $1.85 Million - $2.37 Million	-24,200 Reduced 21.84%	86,600 $7.92 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $79,467 - $116,202	-1,265 Reduced 1.13%	110,800 $8.74 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $62,808 - $69,920	-800 Reduced 0.71%	112,065 $9.73 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $130,944 - $141,984	-1,600 Reduced 1.4%	112,865 $9.44 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $4,008 - $4,675	55 Added 0.05%	114,465 $9.63 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $1.49 Million - $1.81 Million	-22,555 Reduced 16.47%	114,410 $9.15 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $2.13 Million - $2.41 Million	-32,500 Reduced 19.18%	136,965 $9.91 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.06%	169,465 $12.4 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $3.23 Million - $3.56 Million	-56,100 Reduced 24.86%	169,565 $10.3 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $422,025 - $477,150	-7,500 Reduced 3.22%	225,665 $13.5 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $649,528 - $695,387	-12,100 Reduced 4.93%	233,165 $13.3 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $961,200 - $1.07 Million	-20,000 Reduced 7.54%	245,265 $13.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	265,265	265,265 $12.9 Million

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Abbott Laboratories Transaction History